Advertisement
Advertisement

RVPH

RVPH logo

Reviva Pharmaceuticals Holdings, Inc. Common Stock

0.86
USD
Sponsored
-0.01
-0.74%
May 08, 15:59 UTC -4
Closed
exchange

After-Market

0.85

-0.01
-0.58%

Reviva Pharmaceuticals Holdings, Inc. Common Stock Profile

About

Reviva Pharmaceuticals Inc. is a clinical stage pharmaceutical company. It engages in developing therapies to address unmet medical needs in the areas of central nervous system, cardiovascular, metabolic and inflammatory diseases. The company's lead product candidate includes RP5063, for the treatment of schizophrenia, bipolar disorder and major depressive disorder. Reviva Pharmaceuticals Inc., formerly known as Tenzing Acquisition Corp., is based in NEW YORK.

Info & Links

CEO

Laxminarayan Bhat

Headquarters

10080 N. WOLFE ROAD, SUITE SW3-200
CUPERTINO, CA 95014, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.revivapharma.com

Auditor

Baker Tilly US, LLP

Share holders

186

Employees

14

Reviva Pharmaceuticals Holdings, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

10.90M

Enterprise Value

-3.13M

Enterprise Value/EBITDA(ttm)

0.15

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.57

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-959.78%

Return on Invested Capital(ttm)

1335.58%

Return on Assets(ttm)

-162.27%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-20.20M

Net Income Available to Common(ttm)

-19.86M

Diluted EPS(ttm)

-9.20

Share Statistics

Beta (5Y Monthly)

0.64

52-Week Change

-94.76%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

12.81M

Dividend Yield

0.00%

Float4

11.67M

% Held by Insiders

8.90%

% Held by Institutions

63.18%

Balance Sheet

Total Cash(mrq)

14.44M

Total Cash Per Share(mrq)

1.13

Total Debt(mrq)

406.90K

Total Debt/Equity(mrq)

4.71%

Current Ratio(mrq)

2.08%

Quick Ratio(mrq)

2.08%

Book Value Per Share(mrq)

1.47

Cash Flow

Operating Cash Flow Per Share(ytd)

-6.78

Free Cash Flow(ytd)

-24.59M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement